Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Andrew T. Braun"'
Autor:
Yaoli, Yang, Trina, Hollatz, Zubin, Mukadam, Anita, Laxova, Catherine, Decker, Andrew T, Braun
Publikováno v:
In Journal of Cystic Fibrosis January 2021 20(1):127-132
Autor:
Andrew T. Braun, Christina B. Barreda, Ryan J. Coller, Jens C. Eickhoff, Philip M. Farrell, Anita Laxova, Michael J. Rock
Publikováno v:
J Cyst Fibros
BACKGROUND: The Wisconsin Cystic Fibrosis Neonatal Screening Project was a randomized clinical trial (RCT) revealing that children receiving an early diagnosis of CF via newborn screening (NBS) had improved nutritional outcomes but similar lung disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8be4d79870da5ad24771bc5a2938b2d2
https://doi.org/10.1016/j.jcf.2020.06.002
https://doi.org/10.1016/j.jcf.2020.06.002
Autor:
Matthias Boentert, Andrew T. Braun, Jens Spiesshoefer, Anna Heidbreder, Winfried Randerath, Anna Christina Meyer, Hartmut Schneider, Christian Thiedemann, Nina Christina Siebers, Peter Young, Michael Dreher
Publikováno v:
Sleep & Breathing = Schlaf & Atmung
Purpose In neuromuscular disorders (NMD), inspiratory muscle weakness may cause sleep-related hypoventilation requiring non-invasive ventilation (NIV). Alternatively, nasal high flow therapy (NHF) may ameliorate mild nocturnal hypercapnia (NH) throug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0031b82834ff5f659014111f1240f68
http://europepmc.org/articles/PMC7708892
http://europepmc.org/articles/PMC7708892
Autor:
Paolo Sciarrone, Alberto Giannoni, Winfried Randerath, Michael Dreher, Simon Herkenrath, Christian Thiedemann, Matthias Boentert, Claudio Passino, Hartmut Schneider, Jens Spiesshoefer, Britta Bannwitz, Andrew T. Braun, Michele Emdin, Michael Mohr
Publikováno v:
Sleep & Breathing = Schlaf & Atmung
Sleep and breathing 25(2), 705-717 (2021). doi:10.1007/s11325-020-02159-1
Sleep and breathing 25(2), 705-717 (2021). doi:10.1007/s11325-020-02159-1
Sleep and breathing 25(2), 705-717 (2021). doi:10.1007/s11325-020-02159-1
Published by Springer, Berlin
Published by Springer, Berlin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ad04f9d281fceaea542707ac9ec85b
http://europepmc.org/articles/PMC8195975
http://europepmc.org/articles/PMC8195975
Autor:
Olufunmilola Abraham, Megan Buechel, Sommer Gay, Lisa Szela, Catherine A. Decker, Andrew T. Braun
Publikováno v:
J Pediatr Pharmacol Ther
OBJECTIVE Cystic fibrosis (CF) is a genetic disease that requires complex, lifelong treatment regimens to maintain health and reduce disease progression. The aims of this study were 1) to gain the perspectives of multiple health professions to unders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b50fa1c76314837b39586cf42346e5fa
https://pubmed.ncbi.nlm.nih.gov/35350161
https://pubmed.ncbi.nlm.nih.gov/35350161
Publikováno v:
Clinics in Chest Medicine. 39:391-400
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that always affects the respiratory muscles. It is characterized by degeneration of motor neurons in the brain and spinal cord. Respiratory complications are the most com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc612d721c1161363b7f458e04e92a29
https://doi.org/10.1016/j.ccm.2018.01.003
https://doi.org/10.1016/j.ccm.2018.01.003
Autor:
Christian A. Merlo, Jonathan J. Grant, Mark T. Jennings, Noah Lechtzin, Gina Hong, Andrew T. Braun, Rebecca Dezube, Shruti M. Paranjape, Natalie E. West
Publikováno v:
Annals of the American Thoracic Society. 14:1662-1666
In July 2015, the U.S. Food and Drug Administration approved lumacaftor/ivacaftor for use in patients with cystic fibrosis (CF). This drug targets the primary defect in the CFTR protein that is conferred by the F508del CFTR mutation.As there is limit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08d25b256492719841841a7def5b24d0
https://doi.org/10.1513/annalsats.201701-058oc
https://doi.org/10.1513/annalsats.201701-058oc
Autor:
Elizabeth A. Worthey, Camille L. Birch, Anita Laxova, Brandon Wilk, Donna M. Brown, Philip M. Farrell, Melissa A. Wilk, James Holt, Nadiya Sosonkina, Andrew T. Braun
Publikováno v:
Cold Spring Harbor Molecular Case Studies
Variations in disease onset and/or severity have often been observed in siblings with cystic fibrosis (CF), despite the same CFTR genotype and environment. We postulated that genomic variation (modifier and/or pharmacogenomic variants) might explain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2b629024d10a387cf3988e08853b29d
https://pubmed.ncbi.nlm.nih.gov/32014855
https://pubmed.ncbi.nlm.nih.gov/32014855
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S365
Purpose Studies have shown that markers of socioeconomic status (SES) such as education level and non-private insurance status associate with decreased medical adherence in patients with Cystic Fibrosis (CF), as well as increased CF mortality. Furthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8150f930ae730044c1e608daecc0706
https://doi.org/10.1016/j.healun.2020.01.447
https://doi.org/10.1016/j.healun.2020.01.447
Autor:
Christian A. Merlo, Andrew T. Braun
Publikováno v:
Current Opinion in Pulmonary Medicine. 17:467-472
Purpose of review This review summarizes recently published investigations on issues pertaining to cystic fibrosis (CF) lung transplantation. We specifically focus on indications and candidate selection as well as infectious and noninfectious issues
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c416ae159e6b9327fbb86a277e211f09
https://doi.org/10.1097/mcp.0b013e32834b8bdb
https://doi.org/10.1097/mcp.0b013e32834b8bdb